Skip to main content
Premium Trial:

Request an Annual Quote

Ferenc Csizmadia

ChemAxon has tapped Ferenc Csizmadia as its CEO. He succeeds Alex Drijver, the company's current CEO, who is leaving ChemAxon to work with scientific startups. Ferenc, who is also founder of ChemAxon, has also served as the chairman of the company's board and its head of research and development. 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.